Fardellone, Patrice
Barnieh, Lianne
Quignot, Nadia
Gusto, Gaelle
Khachatryan, Artak
Kahangire, Doreen A.
Worth, Gavin
O’Kelly, James
Desamericq, Gaelle
Article History
Received: 28 June 2021
Accepted: 11 November 2021
First Online: 3 February 2022
Declarations
:
: The protocol for this study was subject to a pre-approval by an ethics committee (CESREES) and the CNIL.
: PF received consulting fees from Amgen GmbH. NQ, GG, and AK are full-time employees of Certara and received consulting fees from Amgen to conduct the study. LB received consulting fees from Certara. GD owns stock and is a full-time employee at Amgen France SAS. DK and JOK are full-time employees at Amgen UK Ltd. GW is a full-time employee at Amgen Europe and holds stock in Amgen.